Psoriasis Treatment in Hospitals in Incheon, South Korea

Hepatology in Incheon deals with differentiation, treatment and prevention of pathologies related to the functioning of the hepatobiliary system – the liver, gallbladder and biliary tract. Thanks to the excellent technical equipment, rich experience of hepatologists and interdisciplinary cooperation, taken as the "golden rule" in all clinics, doctors manage to achieve positive dynamics even in severe pathologies.

The hepatology departments in Incheon are focused on treating the following diseases:

• Viral and toxic hepatitis
• Cirrhosis of the liver
• GI
• Cholecystitis
• Fatty and alcoholic hepatosis
• Autoimmune and metabolic dysfunctions
• Acute and chronic liver failure
• Primary and secondary hepatocellular carcinoma-liver cancer (in cooperation with oncology departments)

The development of a therapeutic plan begins with a comprehensive differential diagnosis, which includes the following measures:

• Laboratory tests, including extended liver tests
• Fibrotest and fibroscan
• Elastography of the liver
• Ultrasonography
• ultrasound of the abdominal organs
• Cholecystography
• Gastroscopy
• Minimally invasive biopsy
• MRI and NMR
• Multi-slice CT scans
• PET-CT scan (if cancer is suspected)

For curative purposes, the following procedures are used:

• Surgical procedures controlled by Da Vinci or O-ARM robots
• Drug therapy with a new generation of drugs
• Lithotripsy (for GI)
• Cell therapy
• Immuno-and biotherapy
• SIRT
• Poly-and mono-chemotherapy according to a personal protocol
• Radiofrequency liver ablation
• Cryoablation of the liver
• Molecular-targeted treatment
• Monoclonal antibody therapy
• Contact and remote radiation therapy

clinics Incheon will provide you with tangible help in the fight against the disease and conduct a rehabilitation program that will consolidate and prolong the therapeutic effect. In extremely severe cases, liver transplantation is performed here, and the speed of the procedure is facilitated by presence of its own donor banks.